Howard W. Robin, President & CEO at NEKTAR THERAPEUTICS (NKTR), sold 73,058 shares at $3.95 ($289K) on 2022-05-16, disclosed to the SEC on 2022-05-17.
Seasonal sale ($289k) by President & CEO — this insider has traded NKTR in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.95 | 36,529 | $144K | 50.0% |
| 2 | $3.95 | 36,529 | $144K | 50.0% |
| Total | $3.95 avg | 73,058 | $289K | 100% |
| Filing → |
| NKTR | SELL | 2026-05-21 | $29K | — | Filing → |
| NKTR | SELL | 2026-02-20 | $31K | — | Filing → |
| NKTR | SELL | 2025-11-25 | $240K | — | Filing → |